Press release
Orphan Drugs Industry: NextGen Technological Advancements, Outlook And industry Shares with leading Key Players Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals,
Orphan Drugs
Orphan Drugs is vaccine, medicine, or in-vivo diagnostic agent that is intended to treat, diagnose, and prevent a rare disease (or) rare medical condition, the condition itself being as an orphan disease. Due to the small patient pool, rare diseases were not ranked high on the priority list of health budget allocations and stayed out of industry focus for several years. Additionally, many pharma players failed to recognize the hidden potential behind these rare indications and did not put much focus on developing drugs for these indications.
The demand for the orphan drugs has increased significantly owing to surge in prevalence of rare diseases. In addition, the rise in awareness among the populace regarding rare diseases, increase in R&D investment, and drug development drive the market growth. The impact of the driving factors is expected to overcome the effect of restraints. Moreover, growth in novel indications for known orphan drugs and untapped emerging economies are expected to provide new market opportunities to orphan drug manufacturers in the near future.
This report studies Orphan Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Request a sample copy: https://www.worldwidemarketreports.com/sample/82196
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
By Application, the market can be split into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Orphan Drugs Market Professional Survey Report 2017
1 Industry Overview of Orphan Drugs
2 Manufacturing Cost Structure Analysis of Orphan Drugs
3 Technical Data and Manufacturing Plants Analysis of Orphan Drugs
4 Global Orphan Drugs Overall Market Overview
5 Orphan Drugs Regional Market Analysis
6 Global 2012-2017E Orphan Drugs Segment Market Analysis (by Type)
7 Global 2012-2017E Orphan Drugs Segment Market Analysis (by Application)
8 Major Manufacturers Analysis of Orphan Drugs
9 Development Trend of Analysis of Orphan Drugs Market
9 Development Trend of Analysis of Orphan Drugs Market
9.1 Global Orphan Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Orphan Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Orphan Drugs Sales Price Forecast
9.2 Orphan Drugs Regional Market Trend
9.2.1 North America 2017-2022 Orphan Drugs Consumption Forecast
9.2.2 China 2017-2022 Orphan Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Orphan Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Orphan Drugs Consumption Forecast
10 Orphan Drugs Marketing Type Analysis
11 Consumers Analysis of Orphan Drugs
Else place an Inquire before Purchase “Global Organic Avocado Oil Market Professional Survey Report 2018": https://www.worldwidemarketreports.com/quiry/82196
If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR:
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Industry: NextGen Technological Advancements, Outlook And industry Shares with leading Key Players Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals, here
News-ID: 1259529 • Views: …
More Releases from Worldwide Market Reports
Nucleic Acid Labeling Market: Industry Trends, Share, Size, Growth, Opportunity …
Burlingame, United States - September 3, 2025. Worldwide Market Reports has added a new research study on the Global Nucleic Acid Labeling Market 2025 by Size, Growth, Trends, and Dynamics, Forecast to 2032. This comprehensive report examines labeling chemistries, detection workflows, market drivers, constraints, and competitive dynamics across enzymatic, chemical, and direct labeling methods driving research and diagnostics applications.
The market is segmented by labeling type-radioactive, fluorescent, biotin, and digoxigenin-and by…
Electrophoresis Reagents Market: Industry Trends, Share, Size, Growth, Opportuni …
Burlingame, United States - September 3, 2025. Worldwide Market Reports has added a new research study on the Global Electrophoresis Reagents Market 2025 by Size, Growth, Trends, and Dynamics, Forecast to 2032, which provides a detailed examination of market patterns. This report covers a comprehensive investigation of the factors influencing the market, including reagent manufacturers, distribution channels, key product innovations, and end-user requirements. It delivers insights into the aspects driving…
Specialty Fats & Oils Market Outlook 2025-2032: Size, Growth Drivers, Technology …
Burlingame, United States - September 3, 2025. Worldwide Market Reports announces a new comprehensive study on the Global Specialty Fats & Oils Market, covering market size, share, growth drivers, technology innovations, and regional forecasts through 2032 to support strategic planning and investment decisions.
This report delivers an overview of emerging specialty fat chemistries-such as cocoa butter equivalents, shea stearin, lauric fats, and hardstocks-and their applications across bakery, confectionery, dairy alternatives, cosmetics,…
Textile Recycling Market: Industry Trends, Share, Size, Growth, Opportunity and …
Burlingame, United States - September 3, 2025. A new Report by Worldwide Market Reports, titled "Textile Recycling Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032," offers a comprehensive analysis of the industry, which comprises insights on the Textile Recycling market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well…
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
